Neuroscience Clinical Trials
When most people think of medical research they assume that the most advanced research comes from academic affiliations. But here at Cook Children's, we challenge that assumption. Our medical team is deeply involved in research of all kinds. We look for better ways to diagnose, treat and prevent neurological conditions ... and we look for ways to cure them.
Cook Children's is at the forefront of leading-edge clinical research and our specialists are actively participating in studies investigating a variety of conditions including epilepsy, stroke and neuromuscular disorders.
Active trials
-
A 2-part Phase 2 Study of Safety, Pharmacokinetics and Biomarkers in Children with Duchenne Muscular Dystrophy including a Randomized, Double-Blind, Placebo-Controlled Part A, Followed by an Open-Label Part B
Primary Investigator: Marks MD, Warren
IRB ID: 2023-003 (OPEN)
-
A Long-term Observational Study Evaluating Eteplirsen in Patients with Duchenne Muscular Dystrophy under Conditions of Routine Clinical Practice
Primary Investigator: Marks MD, Warren
IRB ID: 2019-007 (OPEN)
-
A Multimodal Biomarker-based Predictive Model for Infantile Spasm
Primary Investigator: Keator MD, Cynthia
IRB ID: 2022-006 (OPEN)
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-921352 as Adjunctive Therapy in Subjects with SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
Primary Investigator: Perry MD, M. Scott
IRB ID: 2020-071 (OPEN)
-
A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2).
Primary Investigator: Perry MD, M. Scott
IRB ID: 2022-017 (OPEN)
-
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study to Examine the Efficacy and Safety of Zx008 in Subjects with CDKL5 Deficiency Disorder Followed by an Open-Label Extension
Primary Investigator: Perry MD, M. Scott
IRB ID: 2021-093 (OPEN)
-
A Prospective, Long Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy
Primary Investigator: Marks MD, Warren
IRB ID: 2019-052 (OPEN)
-
A Prospective, Long-Term, Interventional, Active Extension Study to Evaluate the Safety and Tolerability of NBI-921352 as Adjunctive Therapy in Subjects with SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
Primary Investigator: Perry MD, M. Scott
IRB ID: 2022-021 (OPEN)
-
Activa® Dystonia Therapy
Primary Investigator: Marks MD, Warren
IRB ID: 593 (OPEN)
-
Brain functional reorganization as a result of deep-brain stimulation therapry in children with dystonia
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2021-009 (OPEN)
-
Cognitive and Neuroimaging Biosignatures of Well-being in Youth with and without Seizures
Primary Investigator: Cooper, Crystal
IRB ID: 2020-104 (OPEN)
-
Electrophysiological Biomarkers of GABA Metabolism in Children with Genetic Epilepsy Syndromes
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2022-055 (OPEN)
-
Electrophysiological Biomarkers of GABA metabolism in children with SCN1A+ Dravet Syndrome
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2022-051 (OPEN)
-
Evaluation of the outcome of surgical intervention on the upper extremity in young patients with hemipelgia
Primary Investigator: Marshall MD, James
IRB ID: 2020-098 (OPEN)
-
Ictal and Interictal High-Frequency Electrophysiological Activity for the Localization of the Epileptogenic Zone in Children with Refractory Epilepsy
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2019-070 (OPEN)
-
Long-term Antipsychotic Pediatric Safety Trial (LAPS)
Primary Investigator: Bailey PhD, Laurie
IRB ID: 2019-078 (OPEN)
-
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS)
Primary Investigator: Perry MD, M. Scott
IRB ID: 2021-048 (OPEN)
-
Multi-modal neuroimaging in children with cerebral palsy to assess functional and anatomical reorganization in relation to sensory and motor functions
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2019-068 (OPEN)
-
Neuromuscular Observational Research (MOVR) Data Hub Protocol
Primary Investigator: Marks MD, Warren
IRB ID: 2019-055 (OPEN)
-
Parental Attitudes in Neonatal Clinical Trial Enrollment: Decision-Making Preferences and Reasoning among Participants and Non-Participants
Primary Investigator: Riley MD, David
IRB ID: 2017-016 (OPEN)
-
Pediatric International DBS (PEDiDBS) Registry
Primary Investigator: Marks MD, Warren
IRB ID: 2016-013 (OPEN)
-
Phase 3 trial for patients with Dyskinetic Cerebral Palsy
Primary Investigator: Marks MD, Warren
IRB ID: 2022-027 (OPEN)
-
Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2019-085 (OPEN)
-
Retrospective data analysis of neurophysiological data for intraoperative or epilepsy monitoring
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2022-059 (OPEN)
-
Retrospective non-interventional study of stiripentol use in Dravet patients in the USA.
Primary Investigator: Perry MD, M. Scott
IRB ID: 2022-113 (OPEN)
-
Robot-assisted hand training to induce manual functional change and cerebral neural plasticity in children with cerebral palsy
Primary Investigator: Papadelis, PhD, Christos
IRB ID: 2021-012 (OPEN)
We're here to help.
If your child has been diagnosed, you probably have lots of questions. We can help. If you would like to schedule an appointment, refer a patient or speak to our staff, please call our offices at 682-885-2500.